Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fennec Pharmaceuticals Q3 EPS $(0.31) Down From $(0.16) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.
byBenzinga Newsdesk
November 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.31) per share. This is a 93.75 percent decrease over losses of $(0.16) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts